Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen and Prodesse to Collaborate on Infectious Disease Tests

NEW YORK, Sept. 10 (GenomeWeb News) - Nanogen and Prodesse announced today a collaboration to develop microarray-based tests for infectious disease agents such as influenza, West Nile virus, and SARS.


Prodesse, a Milwaukee, Wis.-based firm will provide its multiplex amplification technology for use on San Diego-based Nanogen's NanoChip platform, the companies said in a statement. The two firms will create gene-based testing products for marketing to health care providers and clinical reference labs.


Financial details of the deal were not disclosed.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.